GlassScriptPhysician profile
Michael R Crone
NPI 1205875556
$6,897.22
in general payments reported to CMS, 2019-2025
24 companies · $410 in 2025
The $410 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,319 · 2020: $108 · 2021: $1,797 · 2022: $2,780 · 2023: $140 · 2024: $344 · 2025: $410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $894.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $893.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $2,990.27 | 2021-2025 | Barrigel, Urolift |
| Boston Scientific Corporation | $1,166.57 | 2019-2023 | Lithovue |
| Neotract INC. | $928.21 | 2019-2020 | |
| Lumenis, INC | $601.70 | 2021 | |
| Astellas Pharma US INC | $234.84 | 2019-2024 | Xtandi |
| Medtronic, INC. | $173.18 | 2021-2024 | Interstim |
| Coloplast Corp | $139.55 | 2024 | |
| Comsort, INC | $100.00 | 2019 | |
| Healthtronics Stone Solutions, LLC | $87.14 | 2019 | |
| Stryker Corporation | $67.41 | 2021 | |
| Novartis Pharmaceuticals Corporation | $58.51 | 2019 | |
| Janssen Biotech, INC. | $49.99 | 2025 | Erleada |
| Myovant Sciences INC. | $48.47 | 2021 | |
| Varian Medical Systems, INC. | $41.82 | 2020 | |
| Sumitomo Pharma America, INC. | $36.65 | 2023-2025 | Gemtesa |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agiliti Surgical, INC. | $24.42 | 2025 | Koelis Trinity Mri/US Fusion, Siemens Healthineers Varian Cryocare, Sonablate Hifu |
| Beone Medicines USA, INC. | $22.14 | 2025 | Brukinsa |
| Telix Pharmaceuticals | $21.91 | 2025 | Illuccix |
| Integra Lifesciences Corporation | $20.57 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Pacira Pharmaceuticals Incorporated | $19.97 | 2025 | Exparel |
| Endo Pharmaceuticals INC. | $17.96 | 2019 | |
| Melinta Therapeutics, LLC | $16.08 | 2020 | |
| Pfizer INC. | $15.54 | 2020 | |
| Urovant Sciences INC | $14.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Crone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.